Bioventus Inc. (BVS) vs CeriBell, Inc. (CBLL)

A side-by-side comparison of Bioventus Inc. and CeriBell, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BVS vs CBLL

growth of $100 · dividends reinvested · last 2y
BVS +11.5% (+5.6%/yr)CBLL -0.6% (-0.3%/yr)BVS compounded faster over this window
406080100120Start $10020252026$111$99
BVS CBLL

BVS vs CBLL: by the numbers

  • •CBLL is the larger company ($931M vs $898M market cap).
  • •BVS is profitable (9.36% net margin) while CBLL runs a net loss (-64.73%).

Metrics side by side

Valuation

MetricBVSCBLL
P/E ratio17.21N/A
Forward P/E17.02N/A
P/S ratio1.549.13
P/B ratio3.937.26
EV / EBITDA10.58N/A
FCF yield10.50%N/A

Profitability

MetricBVSCBLL
Gross margin68.00%88.90%
Operating margin10.63%-68.62%
Net margin9.36%-64.73%
ROE23.86%-51.43%
ROIC11.37%-46.54%

Growth (annualized)

MetricBVSCBLL
Revenue CAGR (5Y)11.82%N/A
EPS CAGR (5Y)-5.03%N/A
FCF CAGR (5Y)43.36%N/A
Total return CAGR (5Y)-0.81%N/A

Frequently asked

Is BVS or CBLL more profitable?
BVS runs the higher net margin — BVS at 9.36% versus CBLL at -64.73%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.